187 related articles for article (PubMed ID: 7702720)
1. Triazolo[4,5-f]quinolines. Part VI. Synthesis and evaluation of 9-aminoalkyl(aryl)-2-methyl-2H-[4,5-f]quinolines as anticancer agents. Preliminary results of in vitro screening.
Sanna P; Sequi PA; Paglietti G
Farmaco; 1995 Jan; 50(1):47-54. PubMed ID: 7702720
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-inflammatory activity evaluation of novel 7-alkoxy-1-amino-4,5-dihydro[1,2,4]triazole[4,3-a]quinolines.
Sun XY; Wei CX; Chai KY; Piao HR; Quan ZS
Arch Pharm (Weinheim); 2008 May; 341(5):288-93. PubMed ID: 18389515
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of new 2-amino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazines.
Pomarnacka E; Bednarski PJ; Reszka P; Dziemidowicz-Borys E; Bieńczak A; Werel W; Hałasa R
Eur J Med Chem; 2006 May; 41(5):633-9. PubMed ID: 16488515
[TBL] [Abstract][Full Text] [Related]
4. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
Loriga M; Fiore M; Sanna P; Paglietti G
Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity in vitro of new propargyl thioquinolines.
Boryczka S; Wietrzyk J; Opolski A
Pharmazie; 2002 Mar; 57(3):151-4. PubMed ID: 11933840
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
El-Hawash SA; Habib NS; Kassem MA
Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumoral activity of novel thiazolobenzotriazole, thiazoloindolo[3,2-c]quinoline and quinolinoquinoline derivatives.
Beauchard A; Jaunet A; Murillo L; Baldeyrou B; Lansiaux A; Chérouvrier JR; Domon L; Picot L; Bailly C; Besson T; Thiéry V
Eur J Med Chem; 2009 Oct; 44(10):3858-65. PubMed ID: 19427714
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
Alvarez-Ibarra C; Fernández-Granda R; Quiroga ML; Carbonell A; Cárdenas F; Giralt E
J Med Chem; 1997 Feb; 40(5):668-76. PubMed ID: 9057853
[TBL] [Abstract][Full Text] [Related]
9. In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues.
Al-Soud YA; Al-Masoudi NA; Loddo R; La Colla P
Arch Pharm (Weinheim); 2008 Jun; 341(6):365-9. PubMed ID: 18493972
[TBL] [Abstract][Full Text] [Related]
10. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Zhang Q; Pan J; Zheng RL; Wang Q
Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor screening of new 1,7-diphenyl-3-(1,3-disubstituted-1H-pyrazole-4-carbonyl)-[1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones.
Shawali AS; Sherif SM; Darwish MA; El-merzabani MM
Arch Pharm Res; 2010 Jan; 33(1):55-60. PubMed ID: 20191343
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of pyrimidobenzodiazepine derivatives. New ring systems: triazolo- and tetrazolo-pyrimido-benzodiazepines.
Długosz A
Pharmazie; 1995 Mar; 50(3):180-2. PubMed ID: 7732047
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of unsaturated quinoline derivatives.
Montgomery GJ; McKeown P; McGown AT; Robins DJ
Anticancer Drug Des; 2000 Jun; 15(3):171-81. PubMed ID: 11049085
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and bioevaluation of 22-hydroxyacuminatine analogs.
Grillet F; Baumlová B; Prévost G; Constant JF; Chaumeron S; Bigg DC; Greene AE; Kanazawa A
Bioorg Med Chem Lett; 2008 Mar; 18(6):2143-6. PubMed ID: 18276141
[TBL] [Abstract][Full Text] [Related]
16. 2-cyanoaminopyrimidines as a class of antitumor agents that promote tubulin polymerization.
Zhang N; Ayral-Kaloustian S; Nguyen T; Hernandez R; Beyer C
Bioorg Med Chem Lett; 2007 Jun; 17(11):3003-5. PubMed ID: 17416524
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives.
Al-Soud YA; Al-Dweri MN; Al-Masoudi NA
Farmaco; 2004 Oct; 59(10):775-83. PubMed ID: 15474054
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
